临床外科杂志 ›› 2022, Vol. 30 ›› Issue (3): 261-265.doi: 10.3969/j.issn.1005-6483.2022.03.017

• 论著 • 上一篇    下一篇

中心型肥胖对腹腔镜远端胃癌D2根治术临床疗效的影响

  

  1. 作者单位:100020 首都医科大学附属北京朝阳医院普外科
  • 收稿日期:2021-05-18 接受日期:2021-05-18 出版日期:2022-03-20 发布日期:2022-03-20
  • 通讯作者: 通信作者:李敏哲,Email:leeminzhe@hotmail.com

Effect of central obesity on clinical efficacy of laparoscopic D2 radical gastrectomy for distal gastric cancer

  • Received:2021-05-18 Accepted:2021-05-18 Online:2022-03-20 Published:2022-03-20

摘要: 目的 评价中心型肥胖对腹腔镜远端胃癌D2根治术临床疗效的影响。 方法 收集2013年4月~2021年1月间,于首都医科大学附属北京朝阳医院行腹腔镜远端胃癌D2根治手术的168例病人临床及病理资料。以男性腰围≥85 cm、女性腰围≥80 cm为中心型肥胖进行分组,肥胖组共64例,非肥胖组共104例。采用倾向性评分匹配法平衡两组病人除体重指数(BMI)及腰围之外的临床基线特征,比较匹配后两组手术相关指标、术后并发症指标、术后病理指标及预后指标。 结果   匹配前肥胖组与非肥胖组基础资料(除BMI及腰围)比较,年龄和麻醉危险度评分差异有统计学意义( P <0.05)。1 ∶1匹配后,肥胖组与非肥胖组各有61例病例匹配成功,两组基础资料(除BMI及腰围)比较,差异无统计学意义( P >0.05)。两组手术相关指标比较,肥胖组手术时间为(219.8±33.6)分钟、术中出血量为(156.6±55.1)ml、术后住院时间为(14.6±2.3)天,非肥胖组分别为(198.2±24.7)分钟、(122.1±44.3)ml、(13.4±2.7)天,两组比较差异有统计学意义( P < 0.05);肥胖组术后胃肠功能恢复时间为(3.0±0.8)天,非肥胖组为(2.8±0.9)天,差异无统计学意义( P >0.05)。两组术后并发症指标比较,肥胖组术后共有15例出现22例次并发症,非肥胖组术后共有13例出现18例次并发症,差异无统计学意义( P >0.05)。两组术后病理指标比较,肥胖组淋巴结清扫数为(21.9±4.2)枚、淋巴结转移率为77.0%、阳性淋巴结数为(3.3±2.4)枚、术后pTNM分期Ⅰ/Ⅱ/Ⅲ期为17/23/21,非肥胖组分别为(22.4±5.6)枚、70.5%、(3.1±2.4)枚、19/23/19,差异无统计学意义( P >0.05)。两组预后指标比较,肥胖组术后有16例因肿瘤复发及转移死亡,非肥胖组术后有14例因肿瘤复发及转移死亡,两组总体生存期差异无统计学意义( P >0.05)。 结论 中心型肥胖增加了腹腔镜远端胃癌D2根治术的操作难度,中心型肥胖病人术后恢复更慢,但预后并不受影响。

关键词: 中心型肥胖, 胃肿瘤, 远端胃大部切除术, 腹腔镜, 预后, 倾向性评分匹配法

Abstract: Objective To evaluate the effect of central obesity on the clinical efficacy of laparoscopic D2 radical gastrectomy for distal gastric cancer. Methods The clinical and pathological data of 168 patients with distal gastric cancer who underwent laparoscopic D2 radical gastrectomy in Beijing Chaoyang Hospital Affiliated to Capital Medical University from April 2013 to January 2021 were collected.The male waist circumference ≥85 cm and female waist circumference ≥80 cm were divided into two groups.There were 64 cases in obesity group and 104 cases in non-obesity group.Propensity score matching method was used to balance the clinical baseline characteristics of the two groups except BMI and waist circumference.The operation related indexes,postoperative complications indexes,postoperative pathological indexes and prognostic survival indexes were compared between the two groups after matching. Results Before matching,there were significant differences in age and anesthesia risk score between obese group and non-obese group(except BMI and waist circumference)( P <0.05).After matching,61 cases in obesity group and 61 cases in non-obesity group were matched successfully.There was no significant difference in basic data(except BMI and waist circumference) between the two groups( P >0.05).The operation related indexes of the two groups were compared,the operation time,intraoperative blood loss and postoperative hospital stay were(219.8±33.6)min,(156.6±55.1) ml and(14.6±2.3) days in obese group and(198.2±24.7) min,(122.1±44.3) ml and(13.4±2.7) days in non-obese group,the difference was statistically significant( P <0.05).The recovery time of gastrointestinal function was(3.0±0.8) days in the obese group and(2.8±0.9) days in the non-obese group,the difference was not statistically significant(P >0.05).Comparison of postoperative complications between the two groups,there were 15 patients with 22 complications in the obese group and 13 patients with 18 complications in the non-obese group,the difference was not statistically significant( P >0.05).Comparison of postoperative pathological indexes between the two groups,the number of lymph nodes in obese group was(21.9±4.2),the rate of lymph node metastasis was 77.0%,the number of positive lymph nodes was(3.3±2.4),the number of pTNM stage Ⅰ/Ⅱ/Ⅲ was 17/23/21,and the numbers of non-obese group were(22.4±5.6),70.5%,(3.1±2.4) and 19/23/19,the difference was not statistically significant( P >0.05).Comparison of prognosis and survival indexes between the two groups,there were 16 patients died of tumor recurrence and metastasis in obese group and 14 patients died of tumor recurrence and metastasis in non-obese group.There was no significant difference in overall survival between the two groups The difference was not statistically significant( P >0.05). Conclusion Central obesity increases the difficulty of laparoscopic D2 radical gastrectomy for distal gastric cancer.The recovery of patients with central obesity is slower,but the prognosis is not affected.

Key words: central obesity, stomach neoplasms, distal gastrectomy, laparoscopy, prognosis, propensity score matching

[1] 卢开进 申江峰 贾卫光. 胸腔镜改良喉返神旁经淋巴结清扫治疗食管癌的疗效及对预后的影响[J]. 临床外科杂志, 2022, 30(3): 257-260.
[2] 李玉柱 夏连杰. 膀胱癌病人癌组织中Dickkopf相关蛋白2的表达及与预后的相关性[J]. 临床外科杂志, 2022, 30(3): 280-283.
[3] 陈家财 曾宾华 李金雨 罗辉 林山. 腹腔镜下肾动脉阻断肾部分切除术治疗cT1期肾癌的疗效及对肾功能的影响[J]. 临床外科杂志, 2022, 30(2): 121-124.
[4] 季金涛 康波 苏燕胜. 前列腺特异性膜抗原在前列腺癌组织中的表达与临床病理特征的关系及预后价值[J]. 临床外科杂志, 2022, 30(2): 130-133.
[5] 李云龙 杜正华 张慧敏 解凤妮 李纪鹏. 胃肠胰神经内分泌肿瘤临床治疗及预后分析[J]. 临床外科杂志, 2022, 30(2): 166-170.
[6] 陈建新 林铭 金文海. 腹腔镜辅助胃癌根治术后并发症的Clavien-Dindo分级及影响因素分析[J]. 临床外科杂志, 2022, 30(2): 171-174.
[7] 佘明杰 徐永建 张佩君 付强 卢伟 刘小虎. 早期和延期腹腔镜胆囊切除术治疗胆囊结石性胰腺炎疗效分析[J]. 临床外科杂志, 2022, 30(2): 186-188.
[8] 张明坤 王哲 杨柳 侯兰 张聚良. 黏液性乳腺癌的预后影响因素分析与预后模型构建[J]. 临床外科杂志, 2022, 30(1): 44-50.
[9] 孙政 阙海峰 楼建 徐宏涛. 营养风险指数在Ⅳ期胃癌预后评价中的意义[J]. 临床外科杂志, 2022, 30(1): 58-61.
[10] 黄毅 刘启岑 汪文军 吴哲逸 李磊. 腹腔镜下联合脐内侧皱襞修补治疗小儿腹股沟巨大疝疗效分析[J]. 临床外科杂志, 2022, 30(1): 62-64.
[11] 尚培中 赵臣 蒋童新 宋创业. 脐内侧襞腹外疝一例[J]. 临床外科杂志, 2022, 30(1): 69-70.
[12] 桑庆 王亮 张能维. 腹腔镜下胃旁路术在减重与代谢外科的应用进展[J]. 临床外科杂志, 2021, 29(9): 805-808.
[13] 杨珵璨 戴谦诚 王兵. 腹腔镜胃袖状切除联合单吻合口十二指肠回肠旁路术手术相关问题及研究进展[J]. 临床外科杂志, 2021, 29(9): 809-811.
[14] 明炜 吕建发 刘高利 侯国强 胡海峰 龙杏林 张文涵 谢颂平. 胸腔镜下全食管系膜切除术在食管癌根治术中的应用分析[J]. 临床外科杂志, 2021, 29(9): 827-829.
[15] 王海霖 段光辉 田运 刘宏斌. 肠镜下治疗阑尾术后盲肠-腹壁瘘一例[J]. 临床外科杂志, 2021, 29(9): 846-847.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!